ABBN.SW: $86.10 ▼ -2.46 (-2.78%)ASML.AS: $1,560.80 ▼ -95.00 (-5.74%)ENR.DE: $162.50 ▼ -6.64 (-3.93%)GLEN.L: $535.10 ▼ -0.20 (-0.04%)IFX.DE: $80.56 ▼ -5.38 (-6.26%)NOKIA.HE: $12.14 ▲ 0.14 (1.17%)RIO.L: $7,277.00 ▲ 13.00 (0.18%)AMD: $519.85 ▼ -31.78 (-5.76%)INTC: $132.28 ▼ -8.66 (-6.14%)MU: $1,051.77 ▼ -159.61 (-13.18%)WDC: $670.75 ▼ -61.87 (-8.45%)AAPL: $294.30 ▼ -2.71 (-0.91%)AMZN: $234.11 ▲ 1.32 (0.57%)NVDA: $200.04 ▼ -8.61 (-4.13%)AMAT: $585.88 ▼ -54.30 (-8.48%)CIEN: $459.85 ▼ -0.48 (-0.10%)STX: $1,038.59 ▼ -55.45 (-5.07%)

Company Details

Firefly Neuroscience, Inc.

AIFF - NASDAQ

Identifiants & Marche

Ticker AIFF
ISIN US3179701012
CIK 0000803578
Bourse NASDAQ
Devise USD

Classification

Secteur Technology

Entreprise

Pays CA
Siege N/A
Fondee N/A
Site Web Lien

Description

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.